Pfizer accelerates Crizotinib regulatory procedures
Crizotinib (also known as PF-02341066 or 1066) is an ALK (anaplastic lymphoma kinase) inhibitor of the aminopyridine chemical series. The FDA has granted priority review status for Pfizer‘s
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Millennium Healthcare Solutions subsidiaries include Millennium Coding & Billing Specialists, Millennium ProComm and Millennium Medical Devices. Millennium Coding & Billing Specialists has aligned itself with its strategic partners